المؤلفون: Arjen J. Witkamp, Joost Nederend, Andreas J A Bremers, Philip R. de Reuver, Wilhelmina M U van Grevenstein, Henk M.W. Verheul, Koen P. Rovers, Max J. Lahaye, Niels F. M. Kok, Jurriaan B. Tuynman, Checca Bakkers, Maartje Los, Ignace H. J. T. de Hingh, Anna M.J. Thijs, Patrick H. J. Hemmer, Alexandra R. M. Brandt-Kerkhof, Miriam Koopman, Onno Kranenburg, Petur Snaebjornsson, Marcel G. W. Dijkgraaf, Simon W. Nienhuijs, Arend G. J. Aalbers, Schelto Kruijff, Jacobus W. A. Burger, Tineke E. Buffart, Derk Jan A. de Groot, Esther van Meerten, Iris van 't Erve, Geert-Jan Creemers, Miranda Kusters, Pieter J. Tanis, Eva V. E. Madsen, Remond J.A. Fijneman, Kathelijn S. Versteeg, Djamila Boerma, Cornelis J A Punt, Marinus J. Wiezer

المساهمون: Surgery, CCA - Cancer Treatment and quality of life, Amsterdam Gastroenterology Endocrinology Metabolism, Internal medicine, VU University medical center, Epidemiology and Data Science, APH - Methodology, Oncology, CCA - Cancer Treatment and Quality of Life, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Epidemiologie, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy

المصدر: Rovers, K P, Bakkers, C, Nienhuijs, S W, Burger, J W A, Creemers, G-J M, Thijs, A M J, Brandt-Kerkhof, A R M, Madsen, E V E, van Meerten, E, Tuynman, J B, Kusters, M, Versteeg, K S, Aalbers, A G J, Kok, N F M, Buffart, T E, Wiezer, M J, Boerma, D, Los, M, de Reuver, P R, Bremers, A J A, Verheul, H M W, Kruijff, S, de Groot, D J A, Witkamp, A J, van Grevenstein, W M U, Koopman, M, Nederend, J, Lahaye, M J, Kranenburg, O, Fijneman, R J A, van 't Erve, I, Snaebjornsson, P, Hemmer, P H J, Dijkgraaf, M G W, Punt, C J A, Tanis, P J & de Hingh, I H J T 2021, ' Perioperative systemic therapy vs cytoreductive surgery and hyperthermic intraperitoneal chemotherapy alone for resectable colorectal peritoneal metastases: A phase 2 randomized clinical trial ', JAMA Surgery, vol. 156, no. 8, pp. 710-720 . https://doi.org/10.1001/jamasurg.2021.1642Test
JAMA Surgery, 156(8), 710-720. American Medical Association
JAMA surgery, 156(8), 710-720. American Medical Association
JAMA Surgery, 156(8), 710-720. AMER MEDICAL ASSOC
JAMA Surgery, 156, 710-720
JAMA Surg
JAMA Surgery, 156, 8, pp. 710-720

مصطلحات موضوعية: Male, PROGNOSIS, medicine.medical_treatment, CARCINOMATOSIS, MULTICENTER, Hyperthermic Intraperitoneal Chemotherapy, 030230 surgery, Peritoneal Neoplasms/secondary, law.invention, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], NEOADJUVANT CHEMOTHERAPY, 0302 clinical medicine, FOLFOX, Randomized controlled trial, law, Adenocarcinoma/secondary, Adjuvant/adverse effects, Neoadjuvant therapy, Original Investigation, Bevacizumab/administration & dosage, Cytoreduction Surgical Procedures, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Middle Aged, OPEN-LABEL, CANCER, Neoadjuvant Therapy, Fluorouracil/administration & dosage, Capecitabine/administration & dosage, 030220 oncology & carcinogenesis, FOLFIRI, Leucovorin/administration & dosage, Hyperthermic intraperitoneal chemotherapy, Female, medicine.drug, medicine.medical_specialty, Camptothecin/administration & dosage, Capecitabine, 03 medical and health sciences, Chemotherapy, Adjuvant/adverse effects, Oxaliplatin/administration & dosage, REGRESSION, medicine, MANAGEMENT, Chemotherapy, Humans, Organoplatinum Compounds/administration & dosage, Perioperative Period, Response Evaluation Criteria in Solid Tumors, Aged, Colorectal Neoplasms/pathology, HIPEC, business.industry, Perioperative, Surgery, Reconstructive and regenerative medicine Radboud Institute for Health Sciences [Radboudumc 10], Irinotecan, Mitomycin/administration & dosage, Feasibility Studies, business, CONSENSUS

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::375b682e7bd1c0c6ebfa96df3e48e33eTest
https://hdl.handle.net/11370/c9e531bb-9f62-460d-afc2-636baf20eec6Test

المؤلفون: Anthony, Dohan, Benoit, Gallix, Boris, Guiu, Karine, Le Malicot, Caroline, Reinhold, Philippe, Soyer, Jaafar, Bennouna, Francois, Ghiringhelli, Emilie, Barbier, Valérie, Boige, Julien, Taieb, Olivier, Bouché, Eric, François, Jean-Marc, Phelip, Christian, Borel, Roger, Faroux, Jean-Francois, Seitz, Stéphane, Jacquot, Meher, Ben Abdelghani, Faiza, Khemissa-Akouz, Dominique, Genet, Jean Louis, Jouve, Yves, Rinaldi, Françoise, Desseigne, Patrick, Texereau, Etienne, Suc, Come, Lepage, Thomas, Aparicio, Christine, Hoeffel, Zied, Ladhib

المساهمون: Service de Radiologie [CHU Cochin], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), McGill University Health Center [Montreal] (MUHC), l'Institut de Recherche contre les Cancers de l'Appareil Digestif (IRCAD), CHU Strasbourg, Département radiologie diagnostique et interventionnelle Saint Eloi [CHRU Montpellier], Pôle Digestif [CHRU Montpellier], Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Fédération Francophone de la Cancérologie Digestive, FFCD, Lipides - Nutrition - Cancer [Dijon - U1231] (LNC), Université de Bourgogne (UB)-Institut National de la Santé et de la Recherche Médicale (INSERM)-AgroSup Dijon - Institut National Supérieur des Sciences Agronomiques, de l'Alimentation et de l'Environnement, Centre hospitalier universitaire de Nantes (CHU Nantes), Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon] (UNICANCER/CRLCC-CGFL), UNICANCER, Equipe EPICAD (LNC - U1231), Université de Bourgogne (UB)-Institut National de la Santé et de la Recherche Médicale (INSERM)-AgroSup Dijon - Institut National Supérieur des Sciences Agronomiques, de l'Alimentation et de l'Environnement-Université de Bourgogne (UB)-Institut National de la Santé et de la Recherche Médicale (INSERM)-AgroSup Dijon - Institut National Supérieur des Sciences Agronomiques, de l'Alimentation et de l'Environnement, Institut Gustave Roussy (IGR), Oncologie digestive, Département de médecine oncologique [Gustave Roussy], Institut Gustave Roussy (IGR)-Institut Gustave Roussy (IGR), Université de Paris - UFR Médecine Paris Centre [Santé] (UP Médecine Paris Centre), Université de Paris (UP), Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Centre Hospitalier Universitaire de Reims (CHU Reims), Centre de Lutte contre le Cancer Antoine Lacassagne [Nice] (UNICANCER/CAL), UNICANCER-Université Côte d'Azur (UCA), Centre Hospitalier Universitaire de Saint-Etienne (CHU de Saint-Etienne), Centre Paul Strauss, CRLCC Paul Strauss, Service de chirurgie digestive (CH de La Roche-sur-Yon), Centre Hospitalier Départemental - Hôpital de La Roche-sur-Yon, Service d'oncologie digestive et hépato-gastro-entérologie [Hôpital de la Timone - APHM], Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE), Centre de Cancérologie du Grand Montpellier (CCGM), Centre Hospitalier Saint Jean de Perpignan, Polyclinique de Limoges - site François Chénieux [Limoges], Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Hôpital Européen [Fondation Ambroise Paré - Marseille], Centre Léon Bérard [Lyon], CHU Mont de Marsan, Clinique Saint-Jean Languedoc [Toulouse] (CSJL), Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Centre de Recherche en Sciences et Technologies de l'Information et de la Communication - EA 3804 (CRESTIC), Université de Reims Champagne-Ardenne (URCA), Hôpital Maison Blanche

المصدر: Gut
Gut, BMJ Publishing Group, 2020, 69 (3), pp.531-539. ⟨10.1136/gutjnl-2018-316407⟩

مصطلحات موضوعية: Male, Oncology, Colorectal cancer, medicine.medical_treatment, Leucovorin, Kaplan-Meier Estimate, 030218 nuclear medicine & medical imaging, MESH: Camptothecin / administration & dosage, Camptothecin / analogs & derivatives, Colorectal Neoplasms / drug therapy, Colorectal Neoplasms / pathology, Computational Biology, Female, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Prospective Studies, Prospective cohort study, Aged, 80 and over, Liver Neoplasms, Gastroenterology, MESH: Radiographic Image Interpretation, Computer-Assisted, Response Evaluation Criteria in Solid Tumors, Survival Rate, Tomography, X-Ray Computed, Middle Aged, Bevacizumab, 030220 oncology & carcinogenesis, Cohort, FOLFIRI, Radiographic Image Interpretation, Computer-Assisted, Fluorouracil, Colorectal Neoplasms, Clinical decision making, medicine.drug, Adult, medicine.medical_specialty, [SDV.CAN]Life Sciences [q-bio]/Cancer, MESH: Fluorouracil / administration & dosage, Humans, Leucovorin / administration & dosage, Liver Neoplasms / diagnostic imaging, Computerised image analysis, 03 medical and health sciences, Colorectal metastases, MESH: Adult, Antineoplastic Combined Chemotherapy Protocols / administration & dosage, Bevacizumab / administration & dosage, Camptothecin / administration & dosage, Predictive Value of Tests, Internal medicine, [INFO.INFO-IM]Computer Science [cs]/Medical Imaging, medicine, Chemotherapy, MESH: Liver Neoplasms / secondary, Aged, business.industry, [SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology, medicine.disease, Log-rank test, Irinotecan, Camptothecin, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8075364a64f6848b3680bb08f7c9c30Test
https://doi.org/10.1136/gutjnl-2018-316407Test

المؤلفون: Altan Atakan Özcan, Carol L. Shields, Ibrahim Inan Harbiyeli, Arbil Acikalin, Emine Ciloglu

المصدر: Arquivos Brasileiros de Oftalmologia, Volume: 83, Issue: 2, Pages: 153-156, Published: 09 MAR 2020
Arquivos Brasileiros de Oftalmologia

مصطلحات موضوعية: medicine.medical_specialty, Bevacizumab, Lacrimal apparatus diseases, Doenças do aparelho lacrimal, Diagnosis, Differential, Neoplasias cutâneas, 03 medical and health sciences, 0302 clinical medicine, Biopsy, Carcinoma, medicine, Humans, Basal cell carcinoma, Hair follicle, Bevacizumab/administração & dosagem, Bevacizumab/administration & dosage, medicine.diagnostic_test, business.industry, Carcinoma basocelular, Folículo piloso, Diagnóstico diferencial, General Medicine, RE1-994, Skin neoplasms, Pilomatrixoma, Doenças do cabelo, medicine.disease, Humanos, Lacrimal caruncle, Surgery, Ophthalmology, 030221 ophthalmology & optometry, Carcinoma, basal cell, Hair diseases, Differential diagnosis, Pilomatrix carcinoma, business, medicine.drug

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e4adb0a9b535df805792d91c24b8352Test
https://doi.org/10.5935/0004-2749.20200029Test

المؤلفون: Laura Kowalczuk, Francine Behar-Cohen, Richard F. Spaide, Alejandra Daruich, Alexandre Matet, Ali Dirani, Irmela Mantel, Aude Ambresin, Natacha Turck

المصدر: Retina (Philadelphia, Pa.)
Retina, vol. 37, no. 12, pp. 2226-2237
Retina, Vol. 37, No 12 (2017) pp. 2226-2237

مصطلحات موضوعية: Male, Placental growth factor, retina, Time Factors, Visual acuity, genetic structures, Drug Resistance, Visual Acuity, Angiogenesis Inhibitors, chemistry.chemical_compound, 0302 clinical medicine, Original Study, Aged, Angiogenesis Inhibitors/administration & dosage, Bevacizumab/administration & dosage, Dose-Response Relationship, Drug, Female, Follow-Up Studies, Humans, Intravitreal Injections, Middle Aged, Receptors, Vascular Endothelial Growth Factor/administration & dosage, Receptors, Vascular Endothelial Growth Factor/antagonists & inhibitors, Recombinant Fusion Proteins/administration & dosage, Retina/pathology, Retinal Telangiectasis/diagnosis, Retinal Telangiectasis/drug therapy, Retrospective Studies, Tomography, Optical Coherence/methods, Treatment Outcome, Macular telangiectasia, Aflibercept, macular telangiectasia, aflibercept, General Medicine, Diabetic retinopathy, 3. Good health, Bevacizumab, Vascular endothelial growth factor, 030220 oncology & carcinogenesis, medicine.symptom, Tomography, Optical Coherence, medicine.drug, medicine.medical_specialty, Recombinant Fusion Proteins, 03 medical and health sciences, Ophthalmology, medicine, ddc:576, business.industry, medicine.disease, eye diseases, Surgery, Receptors, Vascular Endothelial Growth Factor, chemistry, 030221 ophthalmology & optometry, Retinal Telangiectasis, sense organs, Ranibizumab, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::152971000b9e76158e1f8fda4a9d0b7dTest
https://doi.org/10.1097/iae.0000000000001424Test

المؤلفون: Philippe Aftimos, Andrea Varga, Jean-Charles Soria, Ahmad Awada, Sandrine Aspeslagh, Arturo A.S. Matos-Pita, Rastilav Bahleda

المساهمون: Medical Oncology

المصدر: Anti-Cancer Drugs. 27:1021-1027

مصطلحات موضوعية: Male, 0301 basic medicine, myalgia, Cancer Research, Colorectal cancer, Uterine Cervical Neoplasms, Gastroenterology, Depsipeptides/administration & dosage, 0302 clinical medicine, Depsipeptides, Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Pharmacology (medical), Prospective Studies, Uterine Cervical Neoplasms/drug therapy, Bevacizumab/administration & dosage, Colorectal Neoplasms/drug therapy, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Middle Aged, Kidney Neoplasms, Bevacizumab, Kidney Neoplasms/drug therapy, Oncology, 030220 oncology & carcinogenesis, Anesthesia, Toxicity, Vomiting, Female, medicine.symptom, Colorectal Neoplasms, medicine.drug, Adult, medicine.medical_specialty, Nausea, Peptides, Cyclic, 03 medical and health sciences, Internal medicine, medicine, Humans, Adverse effect, Carcinoma, Renal Cell, Aged, Pharmacology, Dose-Response Relationship, Drug, business.industry, Cancer, medicine.disease, Neoplasms/drug therapy, 030104 developmental biology, Carcinoma, Renal Cell/drug therapy, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66e5e5c9672f1bb68254623f67ae21b3Test
https://doi.org/10.1097/cad.0000000000000409Test

المؤلفون: Søren Leer Blindbæk, Tunde Peto, Jakob Grauslund

المصدر: Blindbæk, S L, Peto, T & Grauslund, J 2019, ' How do we evaluate the role of focal/grid photocoagulation in the treatment of diabetic macular ede-ma? ', Acta Ophthalmologica . https://doi.org/10.1111/aos.13997Test
Blindbaek, S L, Peto, T & Grauslund, J 2019, ' How do we evaluate the role of focal/grid photocoagulation in the treatment of diabetic macular edema? ', Acta Ophthalmologica, vol. 97, no. 4, pp. 339-346 . https://doi.org/10.1111/aos.13997Test

مصطلحات موضوعية: Vascular Endothelial Growth Factor A, medicine.medical_specialty, Combination therapy, genetic structures, Grid photocoagulation, Diabetic macular edema, Angiogenesis Inhibitors, Functional impact, Macular Edema, maculopathy, Macular Edema/diagnosis, 03 medical and health sciences, 0302 clinical medicine, Laser therapy, SDG 3 - Good Health and Well-being, Angiogenesis Inhibitors/administration & dosage, medicine, Humans, Vascular Endothelial Growth Factor A/antagonists & inhibitors, Laser Coagulation/methods, Diabetic Retinopathy, Laser Coagulation, Bevacizumab/administration & dosage, diabetes, business.industry, General Medicine, Lasers, Semiconductor/therapeutic use, Rescue treatment, Bevacizumab, Clinical trial, Ophthalmology, Treatment Outcome, anti-VEGF, Intravitreal Injections, 030221 ophthalmology & optometry, Diabetic Retinopathy/complications, Radiology, Lasers, Semiconductor, business, 030217 neurology & neurosurgery, Retinal photocoagulation, photocoagulation

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb4a8612e7d88fb08ef3db60919a7a4bTest
https://pure.qub.ac.uk/en/publications/how-do-we-evaluate-the-role-of-focalgrid-photocoagulation-in-the-treatment-of-diabetic-macular-edemaTest(7bb20d1a-fc2b-4062-aa72-11a9616cf67f).html

المؤلفون: Koen P. Rovers, Checca Bakkers, Geert A. A. M. Simkens, Jacobus W. A. Burger, Simon W. Nienhuijs, Geert-Jan M. Creemers, Anna M. J. Thijs, Alexandra R. M. Brandt-Kerkhof, Eva V. E. Madsen, Ninos Ayez, Nadine L. de Boer, Esther van Meerten, Jurriaan B. Tuynman, Miranda Kusters, Nina R. Sluiter, Henk M. W. Verheul, Hans J. van der Vliet, Marinus J. Wiezer, Djamila Boerma, Emma C. E. Wassenaar, Maartje Los, Cornelis B. Hunting, Arend G. J. Aalbers, Niels F. M. Kok, Koert F. D. Kuhlmann, Henk Boot, Myriam Chalabi, Schelto Kruijff, Lukas B. Been, Robert J. van Ginkel, Derk Jan A. de Groot, Rudolf S. N. Fehrmann, Johannes H. W. de Wilt, Andreas J. A. Bremers, Philip R. de Reuver, Sandra A. Radema, Karin H. Herbschleb, Wilhelmina M. U. van Grevenstein, Arjen J. Witkamp, Miriam Koopman, Nadia Haj Mohammad, Eino B. van Duyn, Walter J. B. Mastboom, Leonie J. M. Mekenkamp, Joost Nederend, Max J. Lahaye, Petur Snaebjornsson, Cornelis Verhoef, Hanneke W. M. van Laarhoven, Aeilko H. Zwinderman, Jeanette M. Bouma, Onno Kranenburg, Iris van ‘t Erve, Remond J. A. Fijneman, Marcel G. W. Dijkgraaf, Patrick H. J. Hemmer, Cornelis J. A. Punt, Pieter J. Tanis, Ignace H. J. T. de Hingh, Dutch Peritoneal Oncology Group (DPOG), Dutch Colorectal Cancer Group (DCCG)

المساهمون: Oncology, AGEM - Re-generation and cancer of the digestive system, CCA - Cancer Treatment and Quality of Life, Epidemiology and Data Science, APH - Methodology, Surgery, AGEM - Digestive immunity, Medical Oncology, Rehabilitation Medicine, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Damage and Repair in Cancer Development and Cancer Treatment (DARE), CCA - Cancer Treatment and quality of life, CCA - Imaging and biomarkers, Medical oncology

المصدر: BMC Cancer, 19
BMC cancer, 19(1):390. BioMed Central
BMC Cancer, 19(1). BioMed Central
Rovers, K P, Bakkers, C, Simkens, G A A M, Burger, J W A, Nienhuijs, S W, Creemers, G-J M, Thijs, A M J, Brandt-Kerkhof, A R M, Madsen, E V E, Ayez, N, de Boer, N L, van Meerten, E, Tuynman, J B, Kusters, M, Sluiter, N R, Verheul, H M W, van der Vliet, H J, Wiezer, M J, Boerma, D, Wassenaar, E C E, Los, M, Hunting, C B, Aalbers, A G J, Kok, N F M, Kuhlmann, K F D, Boot, H, Chalabi, M, Kruijff, S, Been, L B, van Ginkel, R J, de Groot, D J A, Fehrmann, R S N, de Wilt, J H W, Bremers, A J A, de Reuver, P R, Radema, S A, Herbschleb, K H, van Grevenstein, W M U, Witkamp, A J, Koopman, M, Haj Mohammad, N, van Duyn, E B, Mastboom, W J B, Mekenkamp, L J M, Nederend, J, Lahaye, M J, Snaebjornsson, P, Verhoef, C, van Laarhoven, H W M, Zwinderman, A H, Bouma, J M, Kranenburg, O, van 't Erve, I, Fijneman, R J A, Dijkgraaf, M G W, Hemmer, P H J, Punt, C J A, Tanis, P J & de Hingh, I H J T 2019, ' Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: Protocol of a multicentre, open-label, parralel-group, phase II-III, randomised, superiority study (CAIRO6) ', BMC Cancer, vol. 19, no. 1, 390 . https://doi.org/10.1186/s12885-019-5545-0Test
BMC Cancer, 19:390. BioMed Central Ltd.
BMC Cancer, 19:390. BMC
BMC Cancer, 19(1):390. BioMed Central
BMC Cancer, Vol 19, Iss 1, Pp 1-15 (2019)

مصطلحات موضوعية: 0301 basic medicine, Male, Cancer Research, medicine.medical_treatment, Clinical Trial, Phase III, Leucovorin, STAGE-II, Clinical Trial, Phase II, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], Cancer development and immune defence Radboud Institute for Health Sciences [Radboudumc 2], NEOADJUVANT CHEMOTHERAPY, 0302 clinical medicine, FOLFOX, Adjuvant/adverse effects, Neoplasm Metastasis, Neoadjuvant therapy, Bevacizumab/administration & dosage, COLON-CANCER, Progression-free survival, Colorectal Neoplasms/drug therapy, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Cytoreduction surgical procedures, Clinical Trial, Combined Modality Therapy, Phase II, Oxaliplatin, Bevacizumab, Fluorouracil/administration & dosage, Oncology, Chemotherapy, Adjuvant, Randomized controlled trial, 030220 oncology & carcinogenesis, Cytoreduction Surgical Procedures/adverse effects, FOLFIRI, Leucovorin/administration & dosage, Hyperthermic intraperitoneal chemotherapy, Female, Fluorouracil, HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY, Peritoneum, medicine.drug, Randomized control trial, Adult, medicine.medical_specialty, MITOMYCIN-C, lcsh:RC254-282, Disease-Free Survival, Colorectal neoplasms, induced, LIVER METASTASES, 03 medical and health sciences, Phase III, Chemotherapy, Adjuvant/adverse effects, Oxaliplatin/administration & dosage, medicine, Genetics, Journal Article, Chemotherapy, Humans, Hyperthermia, Mortality, Perioperative Period, business.industry, Peritoneum/drug effects, Perioperative, Peritoneal Neoplasms/drug therapy, Surgery, Adjuvant chemotherapy, Irinotecan, Reconstructive and regenerative medicine Radboud Institute for Health Sciences [Radboudumc 10], Peritoneal neoplasms, 1ST-LINE TREATMENT, 030104 developmental biology, Hyperthermia, induced, Quality of Life, ADJUVANT TREATMENT, business, 5-FLUOROURACIL/FOLINIC ACID, PLUS BEVACIZUMAB

وصف الملف: image/pdf; application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::410235f4855c4dd4392ec44a9e7244ceTest
https://doi.org/10.1186/s12885-019-5545-0Test

المؤلفون: Sarah Berndt, Gilles Carpentier, Olivier Jordan, Gerrit Borchard, Omar. S. Sakr, Muriel Cuendet

المصدر: Journal of Controlled Release, Vol. 224 (2016) pp. 199-207

مصطلحات موضوعية: Vascular Endothelial Growth Factor A, Angiogenesis Inhibitors/administration & dosage/therapeutic use, medicine.medical_treatment, Pharmaceutical Science, Angiogenesis Inhibitors, 030218 nuclear medicine & medical imaging, chemistry.chemical_compound, Drug Delivery Systems, 0302 clinical medicine, Coating, Zeta potential, Polylysine, Embolization, ddc:615, biology, Bevacizumab, Vascular endothelial growth factor, Vascular endothelial growth factor A, 030220 oncology & carcinogenesis, Chemoembolization, Antibody, Cell Survival/drug effects, medicine.drug, medicine.medical_specialty, Alginates, Cell Survival, Drug Compounding, engineering.material, Antibodies, Cell Line, Excipients, 03 medical and health sciences, Vascular Endothelial Growth Factor A/antagonists & inhibitors/immunology, Bevacizumab/administration & dosage/therapeutic use, medicine, Humans, Chemoembolization, Therapeutic, Particle Size, Antibodies, Blocking, business.industry, Blocking/administration & dosage/pharmacology, Surgery, chemistry, Delayed-Action Preparations, Polylysine/chemistry, engineering, biology.protein, business, Therapeutic/methods, Biomedical engineering

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::955e6e77d4ca7a8cff27bd6d8f939876Test
https://doi.org/10.1016/j.jconrel.2016.01.010Test

المؤلفون: Torben Smidt-Hansen, Niels Viggo Jensen, Frede Donskov, Poul F. Geertsen, Line Brøndum

المصدر: Donskov, F, Jensen, N V, Smidt-Hansen, T, Brøndum, L & Geertsen, P 2018, ' A randomized phase II trial of interleukin-2 and interferon-α plus bevacizumab versus interleukin-2 and interferon-α in metastatic renal-cell carcinoma (mRCC): results from the Danish Renal Cancer Group (DaRenCa) study-1 ', Acta Oncologica, vol. 57, no. 5, pp. 589-594 . https://doi.org/10.1080/0284186X.2018.1433324Test
Donskov, F, Jensen, N V, Smidt-Hansen, T, Brøndum, L & Geertsen, P 2018, ' A randomized phase II trial of interleukin-2 and interferon-α plus bevacizumab versus interleukin-2 and interferon-α in metastatic renal-cell carcinoma (mRCC) : results from the Danish Renal Cancer Group (DaRenCa) study-1 ', Acta Oncologica, vol. 57, no. 5, pp. 589-594 . https://doi.org/10.1080/0284186X.2018.1433324Test

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Recombinant Proteins/administration & dosage, medicine.medical_treatment, Phases of clinical research, Kaplan-Meier Estimate, 0302 clinical medicine, Renal cell carcinoma, Interferon, Antineoplastic Combined Chemotherapy Protocols, Medicine, Bevacizumab/administration & dosage, Hematology, General Medicine, Middle Aged, Kidney Neoplasms, Recombinant Proteins, Bevacizumab, Kidney Neoplasms/drug therapy, Treatment Outcome, 030220 oncology & carcinogenesis, Female, medicine.drug, Interleukin 2, Adult, medicine.medical_specialty, Interferon-alpha/administration & dosage, Disease-Free Survival, 03 medical and health sciences, Internal medicine, Carcinoma, Humans, Radiology, Nuclear Medicine and imaging, Carcinoma, Renal Cell, Aged, business.industry, Interleukin-2/administration & dosage, Cancer, Interferon-alpha, Immunotherapy, medicine.disease, 030104 developmental biology, Carcinoma, Renal Cell/drug therapy, Interleukin-2, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::140f3802d1a95917488d380c8e4d37feTest
https://pubmed.ncbi.nlm.nih.gov/29392960Test

المؤلفون: Osman Melih Ceylan, Seyhan Dikci, Soner Demirel, Turgut Yilmaz

المصدر: Arquivos Brasileiros de Oftalmologia v.81 n.1 2018
Arquivos brasileiros de oftalmologia
Conselho Brasileiro de Oftalmologia (CBO)
instacron:CBO
Arquivos Brasileiros de Oftalmologia, Vol 81, Iss 1, Pp 12-17

مصطلحات موضوعية: Male, Vascular Endothelial Growth Factor A, genetic structures, Glaucoma, Angiogenesis Inhibitors, chemistry.chemical_compound, 0302 clinical medicine, lcsh:Ophthalmology, Reference Values, Vascular endothelial growth factor/antagonists & inhibitors, Laser Coagulation, Bevacizumab/administração & dosage, Gestational age, Retinal detachment, Retinopathy of prematurity, Light coagulation/methods, General Medicine, Combined Modality Therapy, Bevacizumab, Retinal Tear, Treatment Outcome, Intravitreal Injections, Female, medicine.drug, medicine.medical_specialty, Gestational Age, Statistics, Nonparametric, 03 medical and health sciences, Fator A de crescimento do endotélio vascular/antagonistas & inibidores, Ophthalmology, medicine, Humans, Retinopathy of Prematurity, Retinopatia da prematuridade, Fotocoagulação/métodos, Retrospective Studies, business.industry, Infant, Newborn, Infant, Reproducibility of Results, Retinal, medicine.disease, eye diseases, chemistry, lcsh:RE1-994, Vitreous hemorrhage, 030221 ophthalmology & optometry, Bevacizumab/administration & dosage, sense organs, business, 030217 neurology & neurosurgery

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed125da964fb538bf3941e02b6d015d1Test
https://doi.org/10.5935/0004-2749.20180005Test